How AI helps scientists design the next generation of medicines

AI is accelerating biologic drug development by narrowing molecular candidates and enabling faster timelines, with companies like AstraZeneca using AI to tackle previously untreatable diseases. Puja Sapra of AstraZeneca highlights AI's role in optimizing drug design and increasing R&D productivity.